QUZAMTY
DEAD

Serial Number

99578980

Owner

Shanghai Aucta Pharmaceuticals Co., Ltd.

Attorney

Christopher D Olszyk, Jr.

First Use Date

Nov 22, 2025

Filing Date

Jan 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

QUZAMTY Trademark

Serial Number: 99578980

QUZAMTY is a trademark filed by Shanghai Aucta Pharmaceuticals Co., Ltd. on January 5, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Shanghai Aucta Pharmaceuticals Co., Ltd. (11 trademarks)

No. 10, Lane 100, Banxia Road, Pudong New Area
Shanghai 201318 , CN

Entity Type: 99

Trademark Details

Filing Date

January 5, 2026

Registration Date

Not Registered

First Use Anywhere

November 22, 2025

First Use in Commerce

November 22, 2025

Published for Opposition

April 21, 2026

Goods & Services

Ophthalmologic preparations; Allergy medication; Pharmaceutical preparations, namely, appetite suppressants; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical use

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 20, 2026 ETOP
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Jun 20, 2026 MAB5
ABANDONMENT - AFTER PUBLICATION
Jun 20, 2026 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Jun 19, 2026 EXAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2026 REAP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 20, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 20, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 5, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2026 NWOS
NEW APPLICATION ENTERED
Jan 5, 2026 NWAP